Matthew Hart to Cell Line, Tumor
This is a "connection" page, showing publications Matthew Hart has written about Cell Line, Tumor.
Connection Strength
0.120
-
The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis. J Oral Pathol Med. 2019 May; 48(5):389-399.
Score: 0.031
-
Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types. Bioorg Med Chem. 2019 01 01; 27(1):208-215.
Score: 0.030
-
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. RNA Biol. 2018; 15(11):1420-1432.
Score: 0.030
-
Novel polygodial analogs P3 and P27: Efficacious therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma. Int J Oncol. 2018 Dec; 53(6):2627-2636.
Score: 0.030